EPA:DIM Sartorius Stedim Biotech Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sartorius Stedim Biotech SA Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add €285.80 -0.80 (-0.28 %) (As of 09/23/2020 12:00 AM ET) Add Compare Share Today's Range€277.20Now: €285.80▼€289.0050-Day Range€262.00MA: €286.95▼€309.4052-Week Range N/AVolume66,813 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartCompetitorsHeadlines Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. It offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as systems for storage and transportation of intermediate and finished biological products. The company also provides cell cultivation, fermentation, filtration, purification, and fluid management services, which supports its customers to develop and produce drugs. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Sartorius Stedim Biotech. Previous Next 2.4 Community Rank Outperform VotesSartorius Stedim Biotech has received 33 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSartorius Stedim Biotech has received 37 “underperform” votes. (Add your “underperform” vote.)Community SentimentSartorius Stedim Biotech has received 52.86% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sartorius Stedim Biotech and other stocks. Vote “Outperform” if you believe DIM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DIM will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSartorius Stedim Biotech does not currently pay a dividend.Dividend GrowthSartorius Stedim Biotech does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sartorius Stedim Biotech insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange EPA Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolEPA:DIM Previous Symbol CUSIPN/A CIKN/A Webwww.sartorius.com Phone33 4 42 84 56 00Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable €285.80 -0.80 (-0.28 %) (As of 09/23/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive DIM News and Ratings via Email Sign-up to receive the latest news and ratings for DIM and its competitors with MarketBeat's FREE daily newsletter. Sartorius Stedim Biotech (EPA:DIM) Frequently Asked Questions How has Sartorius Stedim Biotech's stock been impacted by Coronavirus (COVID-19)? Sartorius Stedim Biotech's stock was trading at €161.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DIM stock has increased by 77.5% and is now trading at €285.80. View which stocks have been most impacted by COVID-19. Who are some of Sartorius Stedim Biotech's key competitors? Some companies that are related to Sartorius Stedim Biotech include Adherium (ADR), ADM Tronics Unlimited (ADMT), ADM Tronics Unlimited (ADMT), ALR Technologies (ALRT), Analytica (ALT), Anteo Diagnostics (ADO), Avita Medical (AVH), Azure Healthcare (AZV), Cannabix Technologies (BLO), Cochlear (CHEOF), Cochlear (COH), COCHLEAR LTD/ADR (CHEOY), Cyclopharm (CYC), Ellex Medical Lasers (ELXMF) and EMvision Medical Devices (EMV). View all competitors. What other stocks do shareholders of Sartorius Stedim Biotech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius Stedim Biotech investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Apellis Pharmaceuticals (APLS), Aquantia (AQ) and Aquinox Pharmaceuticals (AQXP). Who are Sartorius Stedim Biotech's key executives? Sartorius Stedim Biotech's management team includes the following people: Dr. Joachim Kreuzburg, Chairman & CEO (Age 54)Mr. Heiko Imöhl, VP of Group Financing & Investor RelationsMs. Petra Kirchhoff, VP of Corp. Communications & IR (Age 50)Mr. Gerry Mackay, Exec. VP of Marketing, Sales & Services for Lab Products and Services Division (Age 56) What is Sartorius Stedim Biotech's stock symbol? Sartorius Stedim Biotech trades on the EPA under the ticker symbol "DIM." What is Sartorius Stedim Biotech's stock price today? One share of DIM stock can currently be purchased for approximately €285.80. What is Sartorius Stedim Biotech's official website? The official website for Sartorius Stedim Biotech is www.sartorius.com. How can I contact Sartorius Stedim Biotech? The company can be reached via phone at 33 4 42 84 56 00. This page was last updated on 9/24/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
